Term: subcutaneous Pronunciation: (SUB-kyoo-TAY-nee-us) May 24, 2024October 7, 2025 Description: Beneath the skin. Related Posts:FDA Approves Subcutaneous DARZALEX® in Multiple MyelomaFDA Approves Subcutaneous RITUXAN® Formulation for…FDA Approves Subcutaneous RITUXAN® Formulation for…ASH 2020: Subcutaneous DARZALEX® Plus Pomalidomide…Direct Oral Anticoagulant SAVAYSA® Noninferior to…Subcutaneous DARZALEX® Plus POMALYST® and…